Award

ASBMB names 2024 JBC/Tabor Award winners

Marissa Locke Rottinghaus
March 18, 2024

The American Society for Biochemistry and Molecular Biology has announced the winners of the 2024 Journal of Biological Chemistry/Herbert Tabor Early Career Investigator Awards. All awardees are the first authors of standout JBC papers published the previous year.

The awards are named for the late Herb Tabor, who served as JBC’s editor-in-chief from 1971 to 2012 and upheld the journal’s mission to support the dissemination of science, enhance research visibility and promote scientific equity.

A committee of JBC associate editors selected the five award-winning first authors after carefully reviewing nominations from JBC readership, consulting experts in the field and evaluating the scientific quality and impact of nominated papers.

George DeMartino, a professor of physiology at the University of Texas Southwestern Medical Center and JBC associate editor, oversees the award selections.

“The awardees were all first authors of high quality, rigorous, impactful science that is the hallmark of JBC,” DeMartino said. “These papers are already receiving citations in the literature, and the topics display the breadth of work that is covered by the journal.”

“These early-career scientists represent the next generation of authors, who will undoubtedly continue to contribute knowledge to the scientific community.”

Learn more about these outstanding early-career scientists and their research below.

Jenny Hogstrom

portrait of Jenny Hogstram
Jenny Hogstrim

Jenny Hogstrom is a postdoctoral research fellow, working with Taru Muranen, an assistant professor of medicine at Harvard Medical School. In 2023, Hogstrom received the American Association for Cancer Research–AstraZeneca Breast Cancer Research Fellowship. Before moving to Boston, she completed her Ph.D. at the University of Helsinki. She was recognized for the paper “Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.” Hogstrom and her team developed a cell culture model of hormone receptor-positive, or HR+, breast cancer. They generated patient-derived organoids and matching cancer-associated fibroblasts from patient resections of primary and metastatic HR+ breast cancers. Finally, they showed that HR+ cancer-associated fibroblasts secrete cytokines that promote tumor growth and drive treatment resistance. 

Hannah Kondolf

Portrait of Hannah Kondolf
Hannah Kondolf

Hannah Kondolf is pursuing her M.D. and recently earned her Ph.D. at Case Western Reserve University School of Medicine. She performed research with Derek Abbot, a professor of medicine. Kondolf obtained her bachelor’s degree in human biology, health and society at Cornell University. She was recognized for the paper “Protein engineering reveals that gasdermin A preferentially targets mitochondrial membranes over the plasma membrane during pyroptosis.” This study shows that different gasdermin family members cause cell death via distinct mechanisms. Specifically, Kondolf and her team showed that gasdermin A preferentially targets mitochondria upon activation, unlike gasdermin D, which targets the mitochondria and plasma membrane equally.

Edwin Gabriel Peña Martínez

portrait of Edwin Gabriel Peña Martínez
Edwin Gabriel Peña Martínez

Edwin Gabriel Peña Martínez is a graduate student of biochemistry. He works in the lab of José A. Rodríguez-Martínez, an associate professor of biology at the University of Puerto Rico, Río Piedras. Peña Martínez was recognized for the paper “Prioritizing cardiovascular disease-associated variants altering NKX2-5 and TBX5 binding through an integrative computational approach.” Peña Martínez and his team used a machine learning model to identify and prioritize potential cardiovascular disease-causing single nucleotide polymorphisms, or SNPs. After identifying candidate non-coding SNPs using chromatin immunoprecipitation data of two cardiac transcription factors, NKX2-5 and TBX5, they found five variants that altered transcription factor binding and may cause cardiovascular disease.

Jianchao Zhang

portrait of Jianchao Zhang
Jianchao Zhang

Jianchao Zhang is a research assistant professor at the Southern University of Science and Technology in China. He received his Ph.D. in cell biology from Northeast Normal University and completed postdoctoral training at the Shenzhen Institutes of Advanced Technology. He was recognized for the paper “Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML).” Zhang and colleagues used single amino acid–based proteolysis-targeting chimera, or PROTAC, a system that targets harmful proteins for destruction by hijacking the ubiquitin-proteasome system, to degrade the proto-oncogene BCR–ABL. This fusion kinase drives the progression of chronic myeloid leukemia. This method successfully reduced tumor growth in mice with BCR–ABL positive tumors and could be adapted for broader applications in targeted protein degradation.
 

Gabriela Dias Noske

portrait of Gabriela Dias Noske
Gabriela Dias Noske

Gabriela Dias Noske is a cryogenic electron microscopy–associated researcher at the Brazilian Nanotechnology National Laboratory at the Center for Research in Energy and Materials. Recently, she completed her Ph.D. at the University of Sao Paulo, Brazil, under the guidance of USP professor Glaucius Oliva. Dias Noske completed her undergraduate degree at USP and has performed research on the structure and function of the yellow fever protease. She was recognized for the paper “Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease.” In this study, she and colleagues characterized how clinically approved SARS-CoV-2 antivirals bind to their target, the viral protease, and how mutations in the protease affect their efficacy. Using X-ray crystallography, the team also showed that certain residues within the protease are critical for loss of antiviral potency.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Marissa Locke Rottinghaus

Marissa Locke Rottinghaus is the Editorial Content Manager for ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Attie named honorary professor
Member News

Attie named honorary professor

Aug. 18, 2025

This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

In memoriam: William S. Sly
In Memoriam

In memoriam: William S. Sly

Aug. 11, 2025

He served on the American Society for Biochemistry and Molecular Biology Council in 2005 and 2006 and was an ASBMB member for 35 years.